Audevard is an European pharmaceutical laboratory dedicated to equine health. The Group is driven by innovation and an ambitious drug acquisition strategy. For instance, the Group acquired Ceva Santé Animale's equine range in 2016, and the Imaveral® and Vulketan® drugs from Elanco Animal Health in 2018. Audevard increases everyday its European development : from 25% of sales when Ekkio took over in 2015 to 50% today and expanding.
Investment date: 2015
Exit date: 2021
